Molecular genetics of steroid 5 alpha-reductase 2 deficiency
- PMID: 1522235
- PMCID: PMC329933
- DOI: 10.1172/JCI115954
Molecular genetics of steroid 5 alpha-reductase 2 deficiency
Abstract
Two isozymes of steroid 5 alpha-reductase encoded by separate loci catalyze the conversion of testosterone to dihydrotestosterone. Inherited defects in the type 2 isozyme lead to male pseudohermaphroditism in which affected males have a normal internal urogenital tract but external genitalia resembling those of a female. The 5 alpha-reductase type 2 gene (gene symbol SRD5A2) was cloned and shown to contain five exons and four introns. The gene was localized to chromosome 2 band p23 by somatic cell hybrid mapping and chromosomal in situ hybridization. Molecular analysis of the SRD5A2 gene resulted in the identification of 18 mutations in 11 homozygotes, 6 compound heterozygotes, and 4 inferred compound heterozygotes from 23 families with 5 alpha-reductase deficiency. 6 apparent recurrent mutations were detected in 19 different ethnic backgrounds. In two patients, the catalytic efficiency of the mutant enzymes correlated with the severity of the disease. The high proportion of compound heterozygotes suggests that the carrier frequency of mutations in the 5 alpha-reductase type 2 gene may be higher than previously thought.
Similar articles
-
The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred.J Clin Endocrinol Metab. 1998 Feb;83(2):560-9. doi: 10.1210/jcem.83.2.4535. J Clin Endocrinol Metab. 1998. PMID: 9467575
-
Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.Horm Res. 2004;62(5):259-64. doi: 10.1159/000081893. Epub 2004 Nov 2. Horm Res. 2004. PMID: 15528927
-
Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients.J Clin Endocrinol Metab. 2011 Feb;96(2):296-307. doi: 10.1210/jc.2010-1024. Epub 2010 Dec 8. J Clin Endocrinol Metab. 2011. PMID: 21147889
-
[The importance of DNA analysis in the diagnosis of steroid 5-alpha-reductase deficiency].Ginekol Pol. 1994 Jul;65(7):400-6. Ginekol Pol. 1994. PMID: 8001864 Review. Polish.
-
5-Alpha reductase deficiency: a 40-year retrospective review.Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):483-7. doi: 10.1097/MED.0000000000000116. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 25321150 Review.
Cited by
-
Genotype-phenotype correlation, gonadal malignancy risk, gender preference, and testosterone/dihydrotestosterone ratio in steroid 5-alpha-reductase type 2 deficiency: a multicenter study from Turkey.J Endocrinol Invest. 2019 Apr;42(4):453-470. doi: 10.1007/s40618-018-0940-y. Epub 2018 Aug 21. J Endocrinol Invest. 2019. PMID: 30132287
-
Practical approach to steroid 5alpha-reductase type 2 deficiency.Eur J Pediatr. 2011 Jan;170(1):1-8. doi: 10.1007/s00431-010-1189-4. Epub 2010 Mar 28. Eur J Pediatr. 2011. PMID: 20349245 Review.
-
A new susceptibility locus for hypospadias on chromosome 7q32.2-q36.1.Hum Genet. 2008 Sep;124(2):155-60. doi: 10.1007/s00439-008-0533-5. Epub 2008 Jul 27. Hum Genet. 2008. PMID: 18661284
-
Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese.Hum Genomics. 2024 May 22;18(1):49. doi: 10.1186/s40246-024-00619-3. Hum Genomics. 2024. PMID: 38778357 Free PMC article.
-
Association between SRD5A2 rs523349 and rs9282858 Polymorphisms and Risk of Benign Prostatic Hyperplasia: A Meta-Analysis.Front Physiol. 2017 Sep 12;8:688. doi: 10.3389/fphys.2017.00688. eCollection 2017. Front Physiol. 2017. PMID: 28955247 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases